SCHEMBL1275415

SCHEMBL1275415

Sc1nc(S)c2nc[nH]c2n1

nearest known ligand 0.31

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CSNK2A2 P19784 2/20 0.30
CSNK2A1 P68400 2/20 0.30
TP53 P04637 1/20 0.30
PTGS1 P23219 1/20 0.30
HBB P68871 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
MEN1 O00255 1/20 0.30
RAB9A P51151 1/20 0.30
CSNK2B P67870 1/20 0.30
KMT2A Q03164 1/20 0.30
DYRK1A Q13627 1/20 0.30
CSNK2A3 Q8NEV1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1619168 0.79 LMNA (0.33) MEN1KMT2A
SCHEMBL1193368 0.79 PDPK1 (0.34)
SCHEMBL94773 0.79 GDA (0.33) ALDH1A1HPGDTP53PTGS1HBB
Thioguanine SCHEMBL218891 0.79 PDPK1 (0.37) ALDH1A1HPGDTP53PTGS1HBB
SCHEMBL218201 0.79 CSNK2A1 (0.37) KDM4ECSNK2A2CSNK2A1DYRK1A
SCHEMBL16147073 0.79 CSNK2A1 (0.36) CSNK2A2CSNK2A1
SCHEMBL16146852 0.79 MEN1 (0.36) ALDH1A1HPGDCSNK2A2CSNK2A1SMN1; SMN2
SCHEMBL16145958 0.76 XDH (0.38)
SCHEMBL3388656 0.75
SCHEMBL16146865 0.75 KDM4E (0.30) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368505-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF Tan Kah Kee Innovation Laboratory (CN) 2024-11-07 US claimed
CN-116333706-B Corrosion inhibitor system for acidification with temperature resistance of 180 ℃ and preparation method and application thereof 中国石油天然气股份有限公司 2024-06-14 CN claimed
WO-2023185530-A1 DRY FILM RESIST, PHOTOSENSITIVE DRY FILM, AND COPPER CLAD LAMINATE 杭州福斯特电子材料有限公司 2023-10-05 WO claimed
WO-2023133876-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF 嘉庚创新实验室 2023-07-20 WO claimed
CN-116333706-A Corrosion inhibitor system for acidification with temperature resistance of 180 ℃ and preparation method and application thereof 中国石油天然气股份有限公司 2023-06-27 CN claimed
CN-116339083-A Thick photoresist cleaning solution 安集微电子科技(上海)股份有限公司 2023-06-27 CN claimed
CN-112310290-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-05 CN claimed
CN-114699419-A Use of a PLpro protein inhibitor in a medicament for the treatment or prevention of a novel coronavirus infection 北京大学深圳研究生院 2022-07-05 CN claimed
CN-114660895-A Dry film resist, photosensitive dry film and copper-clad plate 杭州福斯特电子材料有限公司 2022-06-24 CN claimed
CN-114317127-A Fluoride-free cleaning agent, and preparation method and application thereof 嘉庚创新实验室 2022-04-12 CN claimed
CN-112500549-B Synthesis and recycling reprocessing method of recyclable shape memory thermosetting resin 西安交通大学 2021-12-28 CN claimed
CN-112707984-A 4D printing photosensitive resin based on dynamic covalent bond and preparation method thereof 西安交通大学 2021-04-27 CN claimed
CN-112500549-A Synthesis and recycling reprocessing method of recyclable shape memory thermosetting resin 西安交通大学 2021-03-16 CN claimed
CN-112310290-A Quantum dot light-emitting diode and preparation method thereof TCL集团股份有限公司 2021-02-02 CN claimed
CN-112022855-A Use of a PLpro protein inhibitor in a medicament for the treatment or prevention of a novel coronavirus infection 北京大学深圳研究生院 2020-12-04 CN claimed
US-20140303112-A1 Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) ENERGENESIS BIOMEDICAL CO., LTD (TW) 2014-10-09 US claimed
EP-2226330-B1 Charge-switch nucleotides PACIFIC BIOSCIENCES CALIFORNIA (US) 2013-09-18 EP claimed
EP-2226330-A1 Charge-switch nucleotides Pacific Biosciences of California, Inc. (US) 2010-09-08 EP claimed
US-4201582-A MERCAPTO HETEROCYCLIC TONER, SILVER HALIDE, SILVER SALT OF CARBOXYALKYL HETEROCYCLIC THIONE, ORGANIC REDUCING AGNET EASTMAN KODAK COMPANY (US) 1980-05-06 US claimed
US-4136074-A THIOL-CONTAINING COMPOUND CANADA WIRE & CABLE LIMITED (CA) 1979-01-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140303112-A1 Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) PRKAG2, PRKAB2, PRKAG1 KDM4E 3951/4885ALDH1A1 1464/4885HPGD 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.